Chinook
is a Washington-based clinical-stage biopharmaceutical company that researches and develops precision drugs for the treatment of chronic kidney disease... Read moreChinook
is a Washington-based clinical-stage biopharmaceutical company that researches and develops precision drugs for the treatment of chronic kidney disease... Read more
2019
PublicAcquired by Novartis AGNASDAQKDNY
News
Aug 22, 2024
BioPharma Dive
Chinook: Versant reimagines its Chinook success with newest startup launch
Jun 25, 2024
StreetInsider
Press Release: Chinook : Life Sciences BC Announces 2024 Awards Winners
Apr 19, 2024
PRWeb
Press Release: Chinook : EY Announces Marc Laplante of Intentsify as an Entrepreneur Of The Year 2024 New England Award Finalist
Mar 22, 2024
Pharamceutical Technology
Chinook: Chinook Therapeutics files patent for improving kidney function in a subject
Dec 22, 2023
Pharamceutical Technology
Chinook: Chinook Therapeutics files patent for a method of treating diabetic kidney disease
Oct 30, 2023
MedCity News
Chinook: Novartis Drug From $3.2B Deal Succeeds in Phase 3, 2024 FDA Filing Is Planned
Aug 15, 2023
Post Online Media
Chinook: Novartis acquires Chinook Therapeutics for $3.2bn
Aug 14, 2023
Pharamceutical Technology
Chinook: Novartis acquires Chinook for $3.2bn to boost kidney disease pipeline
Aug 12, 2023
Americanbankingnews
Chinook: Q2 2023 Earnings Forecast for Chinook Therapeutics, Inc. (NASDAQ:KDNY) Issued By William Blair
Aug 11, 2023
MarketScreener
Chinook: Novartis Completes Acquisition of Chinook Therapeutics
Chinook Competitors
1
2
3
4
5
6
7
8
9
10